Results 161 to 170 of about 19,917 (245)

Clinical Characteristics of Over‐The‐Counter Drug Misusers in Psychiatric Practice in Japan: Comparison by Type of Drug Misused for the First Time

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
OTC drug misuse has become a significant public health concern among adolescent females in Japan. ABSTRACT Purpose This study aimed to understand the clinical characteristics of individuals who misuse over‐the‐counter (OTC) drugs in psychiatric clinical settings in Japan, and to reconsider approaches to current drug misuse prevention education and ...
Soichiro Omiya, Yuko Tanibuchi, Takashi Usami, Takuya Shimane, Toshihiko Matsumoto   +4 more
wiley   +1 more source

Drug-induced mania and parkinsonism in substance use disorder patient: A case report. [PDF]

Indian J Pharmacol
Gurumoorthi R, Rajendran RS, Murugan A, Thiyagarajan K, Rajanandh MG.   +4 more
europepmc   +1 more source

Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Clozapine (CLOZ) is often avoided in treatment‐resistant schizophrenia with comorbid epilepsy due to seizure risks. We report a successful case managed through a cautious CLOZ titration guided by multimodal monitoring, including clinical scales and blood tests such as C‐reactive protein (CRP), CLOZ levels, and anti‐seizure medication (ASM) levels ...
Toru Horinouchi, Mayusa Mito, Toshiyuki Ishikawa, Yuichi Nakamura, Shuhei Ishikawa, Naoki Hashimoto   +5 more
wiley   +1 more source

Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient. Case Presentation A 49‐year‐old Japanese woman with treatment‐resistant residual schizophrenia exhibited persistent
Yoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura   +2 more
wiley   +1 more source

Medical evaluation of first presentation of psychotic symptoms in children and adolescents. [PDF]

Front Psychiatry
Lavan O, Ganelin-Cohen E, Goldstein A, Mevorach T, Frank S, Apter A, Fennig S, Benaroya-Milshtein N, Krivoy A.   +8 more
europepmc   +1 more source

Mental automatism and exogenous psychosis: the originality of De Clérambault's and Karl Bonhoeffer's theories in substance-related psychoses. [PDF]

Front Psychiatry
Ricci V, Sarni A, Maina G.
europepmc   +1 more source

The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 649-655, June 2026.
ABSTRACT Objective Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated to be an effective and well tolerated treatment for depression, and it is being investigated also for other indications. This study presents the Swedish National Quality Register for rTMS (Q‐rTMS).
S. Melker Hagsäter, Axel Nordenskjöld, Pia Nordanskog, Johan Lundberg, Carl Johan Ekman, Fredrik Hieronymus, Robert Bodén   +6 more
wiley   +1 more source

Response to the Letter to the Editor Titled «Secondary Psychotic Syndromes Should Be Excluded before Assuming Idiopathic Digital "Folie à Trois"». [PDF]

Consort Psychiatr
Banerjee D.
europepmc   +1 more source

Changing the Child: The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental Disorders

Bioethics, Volume 40, Issue 5, Page 482-490, June 2026.
ABSTRACT Scientific advancements offer new possibilities for developing novel treatments for children with monogenic neurodevelopmental disorders (mNDDs), targeting the underlying effects of their condition. Although, in qualitative studies, parents of children with mNDDs have predominantly positive attitudes towards the development of novel treatments,
Sietske A. L. van Till, Maartje H. N. Schermer, Hilgo Bruining, Matthijs Verhage, Eline M. Bunnik   +4 more
wiley   +1 more source

The association between autism and psychosis and the tools used to measure it: An updated systematic review and meta‐analysis

British Journal of Clinical Psychology, Volume 65, Issue 2, Page 374-400, June 2026.
Abstract Objectives Autistic individuals are at increased risk of psychotic experiences and being diagnosed with psychotic disorders. This association may result from methodological issues, including the misinterpretation of psychosis questionnaires by autistic individuals and clinicians' difficulty distinguishing between the conditions.
Michael R. Miles, Dennis Golm, Emma Palmer‐Cooper   +2 more
wiley   +1 more source